Imexpharm's latest marketcap:
As of 06/06/2025, Imexpharm's market capitalization has reached $302.57 M. According to our data, Imexpharm is the 17262th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 302.57 M |
| Revenue (ttm) | 87.71 M |
| Net Income (ttm) | 11.75 M |
| Shares Out | 154.01 M |
| EPS (ttm) | 0.08 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 06/09/2025 |
| Earnings Date | 07/18/2025 |
Imexpharm's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | ₫7.96 T | 10% |
| 12/31/2024 | ₫7.24 T | 82.69% |
| 12/29/2023 | ₫3.96 T | -1.28% |
| 12/30/2022 | ₫4.01 T | -22.62% |
| 12/31/2021 | ₫5.19 T | 38.19% |
| 12/31/2020 | ₫3.75 T |
Company Profile
About Imexpharm Corporation
Imexpharm Corporation is a leading pharmaceutical company based in Vietnam, specializing in the manufacturing, processing, trading, and import-export of a wide range of medical products. Established in 1977, the company operates both domestically and internationally, serving diverse healthcare needs.
Product Portfolio
Imexpharm offers an extensive selection of pharmaceutical products, including:
- Oral and injectable antibiotics
- Digestive, cardiovascular, and diabetes medications
- Central nervous system and musculoskeletal treatments
- Respiratory and ophthalmology solutions
- Analgesic, anti-inflammatory, and antipyretic drugs
- Anti-histamines, anti-allergy, and anti-parasitic medications
- Vitamins, minerals, and dietary supplements
- External-use pharmaceuticals
Additional Services
Beyond pharmaceuticals, Imexpharm is involved in:
- Import and export of medical equipment and supplies
- Supply of chemicals for medicine manufacturing and packaging
- Provision of sterilization and disinfection chemicals
Headquarters: Cao Lanh, Vietnam
Frequently Asked Questions
-
What is Imexpharm's (HOSE-IMP) current market cap?As of 06/06/2025, Imexpharm (including the parent company, if applicable) has an estimated market capitalization of $302.57 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Imexpharm (HOSE-IMP) rank globally by market cap?Imexpharm global market capitalization ranking is approximately 17262 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.